English expand_more apps Products

Search Eduardo Listik

MENU Manage review of

ADAM17 confers temozolomide resistance in human glioblas-toma cells and its expression is regulated by miR-145

EDIT ACTIONS

Journal or Conference
verified Verified
chat Verified
close This review has been verified
The journal and date have been verified and cannot be changed.

Journal or conference you reviewed for

Cancers

Date you performed the review

2023-02-07

Article

Search Article Details

Clear All Fields

DOI

Web of Science accession number

PubMed ID

arXiv ID

Title
ADAM17 confers temozolomide resistance in human glioblas-toma cells

URL

Manuscript ID
cancers-2228940

Add Review Content

Review Content

Manage display preferences

We also consider the preferences of journal, publisher and any authors before displaying a review but will never display
more information than your preferences allow. Please do not publish a review if the journal's prohibits it.
Privacy * Content *
Show journal/conference Hide review content

Delete Record Save

Accelerating innovation © 2022 Clarivate Data Correction Copyright Notice Cookie Settings Follow Us
Training Portal Privacy Statement Cookie Policy 15
 
Product Support Newsletter Terms of Use